Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vor Biopharma
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2026
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 23, 2026
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
May 22, 2026
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
May 22, 2026
Vor Bio Announces $75 Million Private Placement with TCGX
May 22, 2026
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2026